An interdisciplinary team of McMaster researchers is recommending Canadian public health officials change how novel antibiotics are approved, procured and accessed in Canada in order to fight the growing threat of antimicrobial resistance (AMR).
Scientists at McMaster are warning that while the world’s attention is focused on COVID-19, another pandemic, antimicrobial resistance (AMR), is of grave concern.
McMaster logo
McMaster logo
